Lucence Presents Data at 2022 World Conference on Lung Cancer (WCLC) Supporting Utility of Amplicon-Based Liquid Biopsy From Detection Through Treatment
Abstracts presented incorporate Company's ultrasensitive AmpliMark NGS platform to analyze diverse signals in blood including mutations, methylation and T-cell receptor repertoire Lucence will present
Source: finanznachrichten.de